Benchmark Starts Cantel Medical (CMN) at Buy
- Wall Street rises, buoyed by economic data; Dow sets high
- Twitter (TWTR) 'Takeover Money' Moves On as 'Trump Money' Moves In
- Buy Any Seasonal Market Weakness Ahead of Year End Rally - Oppenheimer (SPY)
- After-Hours Stock Movers 12/05: (TXMD) (COUP) (BOBE) Higher; (SB) (LXRX) (STWD) Lower (more...)
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Benchmark initiated coverage on Cantel Medical (NYSE: CMN) with a Buy rating and a price target of $83.00.
Shares of Cantel Medical closed at $72.03 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Goldman Sachs Downgrades Marvell (MRVL) to Sell
- HSBC Starts Morgan Stanley (MS) at Hold
- Credit Suisse Assumes Costco Wholesale (COST) at Outperform